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Protection of CpG islands against de novo DNA
methylation during oogenesis is associated with
the recognition site of E2f1 and E2f2
Heba Saadeh1,2 and Reiner Schulz1*
Abstract
Background: Epigenetic reprogramming during early mammalian embryonic and germ cell development is a
genome-wide process. CpG islands (CGIs), central to the regulation of mammalian gene expression, are exceptional
in terms of whether, when and how they are affected by epigenetic reprogramming.
Results: We investigated the DNA sequences of CGIs in the context of genome-wide data on DNA methylation
and transcription during oogenesis and early embryogenesis to identify signals associated with methylation establishment
and protection from de novo methylation in oocytes and associated with post-fertilisation methylation maintenance. We
find no evidence for a characteristic DNA sequence motif in oocyte-methylated CGIs. Neither do we find evidence for a
general role of regular CpG spacing in methylation establishment at CGIs in oocytes. In contrast, the resistance of most
CGIs to de novo methylation during oogenesis is associated with the motif CGCGC, the recognition site of E2f1 and E2f2,
transcription factors highly expressed specifically in oocytes. This association is independent of prominent known
hypomethylation-associated factors: CGI promoter activity, H3K4me3, Cfp1 binding or R-loop formation potential.
Conclusions: Our results support a DNA sequence-independent and transcription-driven model of de novo CGI
methylation during oogenesis. In contrast, our results for CGIs that remain unmethylated are consistent with a
model of protection from methylation involving sequence recognition by DNA-binding proteins, E2f1 and E2f2
being probable candidates.
Keywords: Epigenetic reprogramming, CpG island, gene expression, DNA methylation, oogenesis, genomic
imprinting, chromatin remodelling
Background
Epigenetics encompass reversible biochemical modifica-
tions of DNA and chromatin that do not change the
underlying DNA sequence but influence its interpret-
ation by the cellular machinery, particularly with respect
to gene expression. Epigenetic modifications are herit-
able across cell divisions so that cell type identity can be
maintained [1]. On the other hand, alterations of epigen-
etic modifications are at the heart of cell lineage choices
during differentiation and, thus, are critical in organism
development [2]. DNA methylation (5-methyl-cytosine;
5mC) and post-translational modifications of histone tail
residues are the epigenetic modifications most immediately
linked to the control of mammalian gene expression, and
their genome-wide profiles form cell type-specific combina-
torial patterns [2].
Epigenetic reprogramming is required to generate the
totipotent zygote, able to generate all embryonic and
extra-embryonic cell types [2]. This is achieved by the
erasure of epigenetic marks, DNA methylation in par-
ticular, on the genomes contributed by the germ cells
and the subsequent establishment of new baseline marks
[2,3]. Epigenetic reprogramming is also required during
gametogenesis to uniformly set up the same, sex-specific
epigenetic profile across all germ cell genomes, irre-
spective of their parental origin [2].
Immediately after fertilisation and when the parental
genomes are still in their separate pronuclei, active
genome-wide demethylation erases DNA methylation
from the sperm-delivered paternal genome [4], though
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specific regions like, for example, paternally imprinted
regions, maintain their methylation [2,5]. The oocyte-
delivered maternal genome is initially protected from de-
methylation [5]. However, during subsequent cleavage
divisions the maternal genome is demethylated passively,
mainly due to the exclusion of Dnmt1 from the nu-
cleus, with the exception of specific regions like, for
example, maternally imprinted regions that remain meth-
ylated [2,5]. A minimum in terms of the overall genome-
wide DNA methylation level is reached at the blastocyst
stage, followed by a phase of genome-wide de novo DNA
methylation that coincides with early embryonic differenti-
ation and development, and completes at around the time
of implantation (Figure 1).
In the germ line, DNA methylation and in particular
parental genomic imprints are reset so that the genomes
of mature gametes epigenetically reflect the sex of the
individual. First, DNA methylation is actively removed
from the genomes of primordial germ cells while they
migrate to and colonise the genital ridge [6,7], a process
that in the mouse completes at E13.5. The genomes of
the developing germ cells are subsequently de novo re-
methylated, a phase that in the male germ line is already
complete prior to birth, while mouse oocytes do not
undergo this process until after birth and only during
their final growth phase, with de novo methylation com-
pleting between the germinal vesicle and meiosis II-
arrested stages [8] (Figure 1).
The changes in DNA methylation levels during the
periods of epigenetic reprogramming outlined above are
overall genome-wide trends. Not all genomic regions
follow these trends. An important exception are CpG
islands (CGIs), CpG dinucleotide-dense regions between
a few hundred and a few thousand nucleotides in length
that are found at approximately 70% of mammalian gene
promoters and play a central role in the regulation of
gene expression [9]. The majority of the approximately
23,000 CGIs in the mouse genome identified by CAP-
seq [10] are unmethylated, resisting de novo DNA
methylation at all times, in contrast to most of the rest
of the genome [11] (Figure 1). However, in the female
germ line, approximately 1,600 CGIs (by extrapolation
from the observed fraction of CGIs) acquire methylation
during oogenesis [12,13]. Almost all of these oocyte-
methylated CGIs remain unmethylated during spermato-
genesis, that is, they are maternal germ line differentially
methylated regions (maternal gDMRs). Almost all ma-
ternal gDMRs are transient in that maternal allele-
specific methylation is lost during post-fertilisation
reprogramming. However, there is yet another excep-
tional subset of 28 CGIs that are part of permanent
maternal gDMRs, that is, those that are protected from
post-fertilisation reprogramming and persist up to at
least E8.5 [14]. Among these are almost all of the ma-
ternally methylated imprinting control regions (ICRs)
that regulate imprinted, parental allele-specific gene
expression [14].
DNA sequence features are known to play a role in
epigenetic reprogramming [15,16]. We therefore
hypothesised that the DNA sequences of the CGIs that
acquire DNA methylation in the oocyte contain charac-
teristic DNA sequence features. Using an ab initio DNA
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Figure 1 DNA methylation reprogramming in pre-implantation mouse embryos (fertilisation to approximately E7.5) and the germ lines
(approximately E7.5 to puberty). The paternal genome undergoes rapid active genome-wide demethylation immediately after fertilisation,
while slower passive demethylation (via DNA replication) affects the maternal genome. Methylation re-establishment occurs at around implantation
and it affects both genomes. In the germ line, primordial germ cells lose their DNA methylation during early (black) and late (green) demethylation
stages that affect different sequence categories, imprinted regions (permanent gDMRs) being among the late demethylated regions. While methylation
is re-established in prenatal male germ cells, in oocytes this process does not complete until after puberty during their final growth stage due to being
activated prior to ovulation. The paternal genome is shown in blue while the maternal genome is shown in red. The green lines refer to specific sets
of CGIs: CGIs in imprinted regions that maintain allele-specific DNA methylation at least until implantation (permanent gDMRs), the majority of CGIs
that maintain their methylation-free state, and CGIs that acquire methylation during oogenesis (gDMRs). The width of the line indicates the relative size
of the respective CGI set. The black line represents both parental genomes. PGCs, primordial germ cells; GV, germinal vesicle oocyte; MII, metaphase II
oocyte; E, embryonic day.
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sequence motif discovery approach [17], we replicate
and elaborate the previously experimentally determined
highly specific association between the above permanent
maternal gDMRs and the TGCCGC motif involved in
their protection from post-fertilisation reprogramming
[16]. The same, thus validated, approach fails to uncover
a DNA sequence motif that is characteristic for oocyte-
methylated CGIs in general. Those CGIs also do not
exhibit a periodic pattern in the spacing of their CpGs,
previously suggested to be involved in the targeting of
de novo DNA methyltransferases [18]. In contrast, our
ab initio approach identifies the CGCGC motif as a
novel characteristic feature of those CGIs that are pro-
tected from de novo methylation during oogenesis. We
show that high CpG density cannot explain this finding.
Furthermore, the association of the CGCGC motif with
the absence of DNA methylation at CGIs in the oocyte
is independent of other factors, such as being an active
promoter in the oocyte or having R-loop formation po-
tential. We find that CGCGC is the recognition site of
E2f1 and E2f2, transcription factors that, together with
co-factors involved in chromatin remodelling, are highly
expressed specifically in oocytes.
Results and discussion
An ab initio motif search identifies the Zfp57/Kap1
recognition site as a characteristic feature of permanent
maternal gDMRs
The DNA methylation on the methylated parental alleles
of permanent gDMRs is maintained post-fertilisation by
the Zfp57/Kap1 protein complex that recognises and
binds to the methylated hexanucleotide TGCCmGC [16].
The motif was identified by overlaying the binding sites
of Zfp57, Kap1 and Setdb1, identified by separate ChIP-
seq experiments, and computing the consensus sequence
over all sites occupied by all three proteins. As proof-
of-principle for our computational approach, we wanted
to determine if a purely DNA sequence-dependent (ab
initio) motif discovery method [17] can reproduce the ex-
perimentally determined association between TGCCGC
and imprinted regions, despite their limited number, and
if so, what the statistical properties of this finding are. We
thus compared the CGIs comprising permanent maternal
gDMRs [see Additional file 1: Table S1], which for simpli-
city we refer to as DMR CGIs, with other classes of CGIs.
Despite the limited number of sequences (n = 28), we
found TGCCGC to be by far the most significantly
(DREME [17]; E < 10-9) enriched motif in DMR CGIs,
relative to CGIs that remain unmethylated in the oocyte
(n = 7,526), as well as relative to oocyte-methylated CGIs
that are not DMR CGIs (n = 1,013; Figure 2.A,B).
In terms of significance, six orders of magnitude sepa-
rated TGCCGC from the next most significantly enriched
distinct motif. We used this property of the E-value
distribution in the case of TGCCGC as a benchmark in
our subsequent ab initio motif searches. Specifically, we
considered a motif to be characteristic of a sequence set
if and only if it was reported as statistically significant
(E <0.05) and constituted an extreme outlier in terms of
significance compared to all other reported distinct motifs.
Thus, a motif being characteristic implies high relative
merit against the background of all reported motifs and,
hence, increases the likelihood that the motif is a true
positive finding. Reliance on only the significance metric
reported by an ab initio method (for example, the DREME
E-value) is prone to bias since the overall scale of the
metric can vary widely depending, in a non-trivial manner,
on variables like the input set sizes, sequence lengths and
(di)nucleotide composition. The notion of a characteristic
motif is generalisable to a characteristic (small) subset of
reported motifs that all are extreme outliers in terms of
significance. Such a subset comprising clearly distinct mo-
tifs could indicate the coordinate binding of multiple
factors. However, in our experiments below, we did not
encounter such subsets.
While being characteristic of DMR CGIs, TGCCGC
is however still present in approximately 40% of the
other oocyte-methylated CGIs so that the mere presence
of TGCCGC is insufficient for protection from post-
fertilisation demethylation (Figure 2.C), implying that
other factors contribute to this mechanism. TGCCGC
being the only characteristic motif renders unlikely that
another DNA-binding protein (complex) with high specifi-
city for a distinct recognition site is also involved. How-
ever, we observed that the enrichment of TGCCGC is not
only due to a relatively large fraction of DMR CGIs in
which it is present, but also due to a high density of occur-
rences (approximately 4 per 1 kbp; Figure 2.D) relative to
other CGI groups. Consistent with the observations in
[16], we find all DMR CGIs apart from Slc38a4 harbour at
least two instances of TGCCGC (there are two TGCCGC
sites within 1 kbp of the Slc38a4 gDMR). Overall, gDMR
size is moderately correlated with the number of TGCCGC
instances (r2 = 0.33; [see Additional file 1: Table S1]). This
suggests that multi-occupancy by the Zfp57/Kap1 protein
complex may be required for the permanent protection of
a region.
Oocyte-methylated CpG islands and promoters upstream
do not harbour characteristic DNA sequence motifs
We hypothesised that the subset of CGIs that become
methylated during oogenesis, unlike the vast majority of
CGIs, may harbour a characteristic DNA sequence motif
that would presumably have a role in targeting the de novo
Dnmt3a/Dnmt3l DNA methylation complex. The same ab
initio DNA sequence motif discovery approach as above
did not identify any significantly enriched motifs and,
hence, no characteristic motif in oocyte-methylated CGIs
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relative to oocyte-unmethylated CGIs. Given the associ-
ation of CGI shores with tissue-specific methylation [19],
we extended our search to CGIs including +/- 1 kbp of
flanking sequence, which yielded sets of nominally signifi-
cant motifs [see Additional file 2: Figure S1.A]. However,
none of the motifs was characteristic as defined above.
Moreover, the reported motifs were rich in TpG/CpA
dinucleotides and devoid of CpGs [see Additional file 2:
Figure S1.A], consistent with sequence evolution of
oocyte-methylated CGIs driven by the high mutation
rate of 5mC to T due to deamination (approximately
tenfold greater rate than for any other substitution mu-
tation) [20]. The results were essentially the same for
CGIs including +/- 2 kbp of flanking sequence (data not
shown), except that the number of reported motifs in-
creased roughly twofold, and their significance values uni-
formly were an order of magnitude smaller. Hence, while
the overall dinucleotide composition of the reported mo-
tifs likely reflects a genuine biological process, individually,
each is unlikely to be a recognition sequence. The in-
creases in the number of reported motifs and the simul-
taneously uniformly decreasing significance values upon
including additional flanking sequence illustrate the above
mentioned issue of bias in the significance metric when
comparing two sets of sequences that increasingly and
systematically differ in their dinucleotide composition.
In the absence of a characteristic motif within the
oocyte-methylated CGIs themselves, we next examined
the sequences of oocyte-active promoters whose tran-
scripts extend across downstream oocyte-methylated
CGIs. A detailed study of the Gnas locus demonstrated
that transcription through the CGIs associated with the
Nespas and Gnas_exon1a permanent maternal gDMRs
is necessary for them to gain DNA methylation during
oogenesis [21]. More recently, a significant positive asso-
ciation between CGI methylation in the oocyte and CGIs
being intragenic relative to oocyte-expressed transcripts
was observed in genome-wide data [13]. We therefore
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Figure 2 TGCCGC motif analyses. (A) DREME results for the DMR CpG islands (CGIs) (n = 28) versus oocyte-methylated CGIs (n = 1,013) comparison.
Motif: a regular expression representation of the motif in IUPAC format. Logo: continuous motif representation (y-axis is information content in bits)
on the forward strand. RC: reverse complement. E-value: statistical significance measure. (B) E-value distributions of DREME-identified motifs in DMR
CGIs versus oocyte-methylated and oocyte-unmethylated CGIs. X-axis: E-value bins on a log10 scale, with text labels referring to the bin centres. Y-axis:
number of motifs with an E-value in the respective bin. (C) Presence statistic for the TGCCGC motif per CGI category with and without +/- 1 kbp
flanking sequences (x-axis). The y-axis represents the percentage of CGIs containing at least one occurrence of the motif. The numbers underneath
each category are the total number of sequences in each CGI group. (D) TGCCGC density per CGI category with and without +/- 1 kbp flanking
sequences. The primary y-axis represents density as occurrences per 1 kbp, while the secondary y-axis shows density relative to the background
density in the whole mouse genome (NCBI build 37). DMRs, maternal permanent gDMR CGIs.
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hypothesised that the oocyte-active promoters from
which these transcripts originate may contain a charac-
teristic sequence motif that is sufficient for the activity
of these promoters, thus ensuring the methylation of the
downstream CGI.
To avoid false positive results, we employed strict cri-
teria to identify oocyte-active promoters from oocyte
RNA-seq, BS-seq, RRBS-seq and H3K4me3 ChIP-seq
data [12,13]. Briefly, transcripts were reconstructed using
the Tuxedo protocol [22], and the region +/- 1 kbp
around the TSS of a transcript was considered a pro-
moter if it overlapped an unmethylated CGI and was
enriched for H3K4me3. This set of promoter sequences
was then split according to whether or not transcripts
originating from the respective promoter contained an
oocyte-methylated CGI. An ab initio motif search analo-
gous to the above, comparing the two promoter sets
(with a downstream oocyte-methylated CGI: n = 103;
without: n = 2,017) did not identify any significantly
enriched motifs. We then systematically expanded the pro-
moter sequences to include +/- 2 kbp, +/- 4 kbp and +/- 5
kbp of sequence flanking the TSS, yielding three, six and
eight nominally significant motifs, none of which was
characteristic as defined above [see Additional file 2:
Figure S1.B].
We note that the observed lack of characteristic se-
quence motifs in oocyte-methylated CGIs or promoters
upstream does not rule out less parsimonious sequence-
based models of DNA methylation establishment. For
example, each of multiple distinct combinations of se-
quence motifs may be sufficient to induce DNA methy-
lation. In theory, none of the individual combinations
needs to form a characteristic set of motifs and, hence,
all could evade detection by our ab initio approach.
CpGs in oocyte-methylated CpG islands are not
characteristically spaced
The Dnmt3a/Dnmt3l (Dnmt3a/l) tetramer protein com-
plex that is responsible for de novo DNA methylation in
oocytes has two active sites so that the complex can
methylate two CpGs separated by 8 to 10 bp at the same
time [18,23]. The authors of [18] also observed that the
spacing of CpGs in twelve of the murine permanent
maternal gDMRs on average exhibited a period of 8 to
10 bp, in contrast to ten CGIs on human Chr 21 and,
therefore, suggested that this sequence feature may be a
targeting signal for the recruitment of Dnmt3a/l. A
subsequent investigation of this possibility by others
provided only qualified support for this notion [24]. We
asked the question whether the CpGs in CGIs that are
de novo methylated by Dnmt3a/l in the oocyte are char-
acteristically spaced.
For the CGIs in each of our three categories (unmethy-
lated CGIs, DMR CGIs, and oocyte-methylated CGIs that
are not DMR CGIs), we computed the average observed
over expected (obs/exp) ratio of the number of pairs of
CpGs at a given distance, for distances up to 200 bp (see
Methods for details). The average obs/exp ratios formed a
periodic pattern for DMR CGIs but not for the other two
CGI categories (Figure 3).
Next, we determined for each CGI the significance of
the observed number of pairs of CpGs at distances be-
tween 8 and 10 bp by comparison to the values obtained
for 1,000 shuffled versions of the CGI sequence with di-
nucleotide frequencies identical to the original sequence
[25]. We found that 43% of unmethylated CGIs are sig-
nificantly (empirical P <0.05) enriched for pairs of CpGs
at 8 to 10 bp, versus 37% of DMR CGIs and only 19% of
the other oocyte-methylated CGIs (Figure 4.A). For pairs
of CpGs at 12 to 14 bp, a distinct range of distances that
does not include multiples of the 8 to 10 bp range, the
results qualitatively differed only for DMR CGIs, only
2% of which were significantly enriched (Figure 4.B).
The smaller proportion (19%) of oocyte-methylated
CGIs enriched for pairs of CpGs in relatively close prox-
imity (8 to 10 bp and 12 to 14 bp) compared to
unmethylated CGIs (39 to 43%) is consistent with the
high mutation rate of 5mC [20] that over evolutionary
time spans is expected to lead to lower CpG density.
This is supported by the TG/CA-rich motifs identified
above in oocyte-methylated relative to unmethylated
CGIs including shores [see Additional file 2: Figure S1].
When we included CGI shores in the analysis of CpG
pairs at 8 to 10 bp, the gap between oocyte-methylated
and unmethylated CGIs became more pronounced [see
Additional file 2: Figure S2], suggesting that the rate of
CpG depletion is higher in the shores than in the cores
of methylated CGIs. In vitro, Dnmt3a/l preferentially
methylates CpG pairs at 8 to 10 bp [23]. Our results
provide no evidence that CpG pairs at 8 to 10 bp are
preferentially depleted in oocyte-methylated CGIs; that
is, the in vitro preference of Dnmt3a/l is not obviously
reflected in the sequence evolution of those CGIs.
The 28 DMR CGIs on average exhibit an approxi-
mately 9-bp period in CpG spacing and are enriched for
CpG pairs at 8 to 10 bp relative to pairs at 12 to 14 bp
(Figures 3 and 4). Individually however, they exhibit con-
siderable variability with respect to the existence of peri-
odic CpG spacing, as well as the lengths of the present
periods, irrespective of the method used to assess peri-
odicity [see Additional file 3: Supplementary Results and
Methods; Additional file 1: Table S2; Additional file 2:
Figures S3-S7]. This lack of consistency, even among
CGIs belonging to the same permanent maternal gDMR,
does not support a general involvement of periodic CpG
spacing in targeting Dnmt3a/l to these regions.
Oocyte-methylated CGIs that are not DMR CGIs (the
vast majority) lack periodic patterns in their average
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obs/exp ratios (Figures 3) and are equally depleted in
CpG pairs at 8 to 10 bp and 12 to 14 bp (Figure 4). We
conclude that regular CpG spacing, particularly with a
period of 8 to 10 bp, is not associated with DNA methy-
lation establishment by Dnmt3a/l at CGIs in the oocyte.
Together with the lack of a characteristic DNA sequence
motif in non-DMR oocyte-methylated CGIs, our results
support a sequence-independent model of de novo DNA
methylation during oogenesis.
A sequence-independent model is compatible with the
transcription elongation-driven model of DNA methyla-
tion establishment in the oocyte proposed in [21] and
supported by the genome-wide results in [13]: of the
CGIs associated with a transcript in the oocyte, 85% of
the unmethylated CGIs were associated with a promoter,
and 75% of the methylated CGIs (including DMR CGIs)
were intragenic. We sought to replicate these findings,
taking into account additional genome-wide data for oo-
cytes [12]. We stratified CGIs according to their methy-
lation state and position relative to transcripts and active
promoters in the oocyte (Figure 5; see Methods for
details). We excluded CGIs for which the classification
was ambiguous, for example, CGIs associated with an
active promoter as well as being intragenic relative to
another transcript. We found almost all unmethylated
CGIs (95%) associated with a transcript to be promoter-
associated, and a large majority (85%) of the transcript-
associated methylated CGIs were intragenic. However,
though we observed an even greater degree of associ-
ation between CGI methylation and intragenic location
than previously reported, not all intragenic CGIs are
methylated in the oocyte.
The CGCGC DNA sequence motif is a characteristic
feature of unmethylated CpG islands in the oocyte
DNA methylation establishment during oogenesis results
in the methylation of most gene body CpGs, while
the CpGs comprising most CGIs remain unmethylated
[12,13]. This includes a set of 259 CGIs that are intragenic
relative to oocyte-expressed transcripts and, therefore,
ought to be methylated given the model of transcription
elongation-driven methylation [21]. Ab initio motif finding
applied to the DNA sequences of these CGIs identified
the motif MCGCGCS as significantly enriched (DREME
E <10-37) in comparison to oocyte-methylated intragenic
CGIs (Figure 6.A). Nine orders of magnitude separated
the motif from the next most enriched motif so that like
the Zfp57/Kap1 motif, it meets our criteria for a charac-
teristic motif (Figure 6.B). The result for repeat-masked
sequences was almost the same (CGCGCS; [see Additional
file 2: Figure S8.A]). For simplicity, in the text below, we
refer to the motif by its core sequence: CGCGC. The motif
is present in 82% of unmethylated intragenic CGIs versus
in 33% of oocyte-methylated intragenic CGIs and, more
generally, in 77% of unmethylated CGIs versus 38%
of oocyte-methylated CGIs (Figure 6.C). The density
of occurrences also is higher in unmethylated CGIs
(Figure 6.D).
The pattern of CGCGC motif density values across the
different CGI categories is very similar to the pattern for
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the CpG dinucleotide [see Additional file 2: Figure S8.B],
which raised the question of whether the motif occur-
rences are a simple consequence of the greater CpG
density of unmethylated CGIs. To test this hypothesis,
we shuffled the sequences of the unmethylated CGIs,
while maintaining dinucleotide frequencies as above
[25], and subsequently determined the occurrences of
the motif. We observed a approximately 45% reduction
in the number of motif occurrences, almost doubling the
number of unmethylated CGIs without a motif occur-
rence and reducing the overall density of occurrences by
38% [see Additional file 2: Figure S8.C-E]. This rules out
the globally high CpG density of unmethylated CGIs as
the cause of the motif occurrences. However, CpGs are
typically not uniformly distributed within a CGI, so the
local CpG density varies within a CGI. Thus, locally high
CpG density may explain the motif occurrences, or at
least a large fraction of them. To test this possibility, we
determined the distribution of the number of motif oc-
currences as a function of local CpG content and com-
pared the distribution obtained for the unmethylated
CGIs with the distribution for their shuffled counter-
parts [see Additional file 2: Figure S9]. Only approxi-
mately 5% of the motif occurrences in unmethylated
CGIs can be explained by high local CpG density. In
conclusion, repetitive sequence elements and high CpG
density are unlikely explanations for the enrichment of
the CGCGC motif in unmethylated CGIs.
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Figure 4 Cumulative distributions of the empirical P value for the observed number of pairs of CpGs 8 to 10 bp (A) and 12 to 14 bp
(B) apart. The empirical P value (likelihood of observing as many or more CpG pairs at 8 to 10 bp/12 to 14 bp by chance) was determined for
each CGI by comparison with 1,000 observations obtained by shuffling the CGI sequence while maintaining the dinucleotide frequencies. Here,
we show the cumulative distributions of this P value among the CGIs in each of the three CGI categories (DMRs: DMR CGIs, other oocyte-methylated
CGIs, and unmethylated CGIs). For a particular P value X, the cumulative distribution value Y equals the proportion of CGIs in the respective category
with P < X. A vertical line marks X = 0.05, the P value threshold that we considered significant. At this threshold, 43%, 37% and 19% of unmethylated,
DMR and other methylated CGIs, respectively, were significantly enriched with CpG pairs at 8 to 10 bp (A), versus 39%, 2% and 19% for CpG pairs at
12 to 14 bp. Overall, CpG pairs at 8 to 10 bp thus are enriched in DMR CGIs relative to CpG pairs at 12 to 14 bp, while no such distance-specific
enrichment is observed for unmethylated or other methylated CGIs. This pattern is robust, that is, holds true for a wide range of P value thresholds.
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The significant association of the CGCGC motif with
unmethylated CpG islands in the oocyte is independent
of other, known hypomethylation-associated factors
Previous work by others has associated the typical lack
of DNA methylation at CGIs with several factors. Pro-
moter activity of a CGI is generally thought to be incom-
patible with CGI methylation [9,26]. R-loop formation
potential of a CGI has been reported as a distinguishing
feature of unmethylated CGIs in human embryonic stem
cells (ESCs) [27]. In mouse ESCs, fibroblasts and brain,
the binding of Cfp1 to CGIs is associated with hypomethy-
lation via recruitment of the Set1 histone methyltransfer-
ase complex that deposits H3K4me3 [28,29]. H3K4me3 in
turn inhibits the Dnmt3a/l complex and, thus, is directly
associated with hypomethylation [30,31]. Here, we investi-
gated these factors together with the CGCGC motif as a
novel fifth factor to estimate the relative strengths of their
association with hypo-methylation of CGIs in the oocyte,
and their inter-dependencies.
We took a logistic linear regression approach, model-
ling the binary methylation state (either methylated or
unmethylated) of 8,567 CGIs in the oocyte as linear
combinations of subsets of binary factors and interaction
terms. We refer to the five factors as PA, Rloop, Cfp1,
H3K4me3 and Motif, and they are defined as follows:
the CGI is/is not an active promoter in the oocyte (PA),
the CGI has/does not have R-loop formation potential
(Rloop), the CGI is/is not bound by Cfp1 in mouse
whole brain tissue (Cfp1), the CGI is/is not enriched for
H3K4me3 in the oocyte (H3K4me3), and the CGI does/
does not contain the CGCGC motif (Motif). We note that
R-loop formation potential, as opposed to actual R-loop
formation, is a DNA sequence- and oocyte transcriptome-
derived feature, termed G-skew in [27], that is, more G
than C residues in the transcribed strand of a CGI.
Thus, apart from Cfp1, all factors incorporate cell
type-independent sequence and/or oocyte-specific ex-
perimental data. The set of factors was non-redundant
since pairwise correlation between factors did not ex-
ceed 0.62 and typically was <0.3 [see Additional file 1:
Table S3]. The values for all factors for all CGIs are
part of Additional file 4 and Additional file 5 (‘Un-
methylated associated Factor’ spreadsheet).
First, we determined which of the five factors in isola-
tion have significant predictive value (reduction in model
deviance) in terms of predicting the methylation state of
a CGI in the oocyte. All factors had significant predictive
value. In terms of effect size (reduction in deviance), the
CGCGC motif was second after H3K4me3, and R-loop
formation potential was a distant last [see Additional file
1: Table S4]. This is in agreement with the observed
levels of correlation between the methylation state and
each of the factors [see Additional file 1: Table S3].
In [27], 65% of human promoter CGIs versus 16.3% of
intragenic CGIs (promoter/intragenic labels derived from
gene annotation) and 67.4% of unmethylated (in human
ESCs) CGIs versus 9.4% of methylated CGIs were ob-
served to have R-loop formation potential. The authors
concluded that ‘unmethylated CGI promoters are highly
associated with strong GC skew and, therefore, with
significant R loop formation potential’. Our finding that
R-loop formation potential is a relatively poor predictor of
the CGI methylation state therefore was surprising. In
mouse oocytes, we find that while 67% of the CGIs at
active promoters have R-loop potential, 54% of the intra-
genic CGIs do also. Similarly, while 67% of CGIs that
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Figure 5 Relationship between the DNA methylation state of CpG islands (CGIs) and their location relative to transcripts in the oocyte.
Almost all CGIs that are unambiguously associated with the promoter of an oocyte transcript are unmethylated. In contrast, a large majority of
the CGIs that are unambiguously (distal) intragenic become methylated in the oocyte. CGIs that do not overlap oocyte transcripts were similarly
classified according to their location relative to annotated genes (UCSC Known Genes). They illustrate that in the absence of actual transcription,
there is no close relationship between CGI gene-relative position and oocyte methylation. The numbers underneath each category are the total
number of CGIs in the respective class.
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remain unmethylated in the oocyte have R-loop potential,
so do 51% of oocyte-methylated CGIs. The former has a
potential explanation in that a substantial fraction of CGIs
that are intragenic in the oocyte may coincide with anno-
tated promoters, but we found that to be true for only ap-
proximately 11% of the intragenic CGIs. The latter is
difficult to reconcile with [27] because the results do not
rely on annotation database content. Since the promoter-
associated versus intragenic labels of CGIs are highly
correlated with their methylation state in the oocyte
(Figure 5), we stratified CGIs according to the label and
separately determined the effect of having versus not hav-
ing R-loop formation potential on the fraction of methyl-
ated CGIs (Figure 7.A). While R-loop formation potential
decreases the fraction of methylated CGIs within both the
promoter-associated and the intragenic CGI categories,
the reductions and associated odds-ratios (OR) are rela-
tively small: 2% (OR: 1.5) for promoter-associated, and
18% (OR: 2.8) for intragenic CGIs. For comparison, the
CGCGC motif reduces the fraction of methylated CGIs by
9% (OR: 4.0) and 37% (OR: 8.8), respectively [Additional
file 2: Figure S10.A]. We conclude that R-loop formation
potential on its own confers relatively little protection
against DNA methylation in the oocyte.
We next tested whether the addition of the Motif fac-
tor to a model comprising one of the other factors sig-
nificantly improved model fit and, hence, whether the
CGCGC motif conveys significant additional, independ-
ent power to predict the methylation state. We found
this to be true for all pairwise combinations of the Motif
factor with one of the other factors [see Additional file
1: Table S4; Additional file 2: Figure S10.B]. This sug-
gests that the presence of the CGCGC motif in a CGI
independently confers additional protection from DNA
methylation in the oocyte, in particular independent of
promoter activity.
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Figure 6 CGCGC motif analyses. (A) Motifs reported by DREME as the most significantly enriched in the set of intragenic unmethylated CpG
islands (CGIs) (n = 259) compared to the set of intragenic methylated CGIs (n = 545). The CGCGC motif is the most significant motif with an
extremely small E-value relative to the other reported motifs. (B) E-value distribution resulting from the de novo motif search comparing unmethylated
intragenic with methylated intragenic CGIs that identified the CGCGC motif. The CGCGC motif is the short bar in the bottom-left corner, reported as
nine orders of magnitude more significant than any of the other identified motifs. Similarly, TGCCGC was six to eight orders of magnitude more
significant than any of the other reported motifs (Figure 2.B). (C) Presence statistic for the CGCGC motif per CGI category. (D) Density of the CGCGC
motif per CGI category. DMRs, maternal permanent gDMR CGIs.
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Finally, we tested each pair of factors for significant
interaction, that is, a significant increase in the predictive
value of the model upon the addition of an interaction
term to the model composed of the two factors (Figure 7.
B). The most significant interaction with by far the largest
effect size occurs between promoter-association and R-
loop formation potential [see Additional file 1: Table S5],
consistent with promoter activity being required to realise
actual R-loop formation at CGIs that have the potential to
do so, and consequently, significant extra protection from
DNA methylation above and beyond the effect of R-loop
potential or promoter-association alone. The effect sizes
of all other significant pair-wise interactions between fac-
tors were relatively small. That includes the only signifi-
cant interaction between the CGCGC motif and another
factor, namely, Cfp1 binding.
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Figure 7 Analysis of hypomethylation-associated factors. (A) R-loop formation potential in distinct CpG island (CGI) groups. The percentages
of methylated (blue) versus unmethylated (red) CGIs within each category are shown. The effect of R-loop formation potential on DNA methylation is
small once CGIs have been stratified into promoter associated (PA) versus intragenic groups. (B) Pairwise significant interaction/correlation network of
hypomethylation-associated factors. The numbers from 1 to 5 (red) indicate the rank of the factors based on the reduction in deviance compared to
the null model which represents their power in predicting CGI methylation state (1 =most predictive value; Table S4). Significant interactions between
factors are represented by black lines labelled with the Bonferroni multiple testing corrected chi-square P value (see Table S5 for a complete list of
pairwise interaction statistics). Factors that are correlated with an absolute Pearson correlation coefficient (CC) >0.29 (the maximum correlation
observed between any of the factors and the methylation state) are connected by grey lines labelled with the CC (see Table S3 for a complete list of
pairwise CCs). (C) The proposed model of how a methylation-free state is established and maintained at oocyte-unmethylated CGIs. We propose that
chromatin remodelling (Swi/Snf via Arid1b) and histone acetyltransferase (Kat5) complexes protect the CGI sequence from de novo methylation by
keeping the CGI nucleosome-free and, therefore, free of the preferred substrate of Dnmt3a/l. They, in turn, are recruited to the CGI by E2f1 and/or E2f2
bound to the CGCGC recognition site in the CGI sequence.
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The CGCGC motif matches the recognition site of E2f1
and E2f2, DNA-binding proteins involved in chromatin
remodelling
We searched the Jaspar and Uniprobe motif databases
for matches of the CGCGC motif to previously reported
recognition sites of DNA-binding proteins. The yeast
proteins RSC3 and RSC30, and the mammalian proteins
E2f1, E2f2, E2f3 and Zfp161, have significantly (FDR <20%)
matching database entries [see Additional file 2: Figure
S11]. The match to E2f1 is supported further by an E2F1
ChIP-seq experiment in human MCF7 cells that identified
CGCGC as the consensus binding sequence [32]. Tran-
scriptionally, E2f1 and E2f2 are highly expressed specifically
in oocytes (>15x of the median expression level across
tissues), in contrast to E2f3 and Zfp161 (aka Zbtb14)
([see Additional file 2: Figure S12], [33] and also [34]).
We re-analysed the E2F1 ChIP-seq data from [32],
identifying 30,467 sites of significant E2F1 enrichment
(over input) and [GG]CGCGC as the most significantly
enriched motif see Additional file 6: Mini-website with
GEM results]. Almost 2/3 of the E2F1 binding sites
overlap a CGI from [10]. Using the transcripts annotated
by UCSC Known Genes (see Methods for details), we
determined that E2F1 is >55x more likely (lower bound
of odds ratio (OR) 95% confidence interval) to bind a CGI
promoter than a non-CGI promoter (Fisher’s exact test;
P <10-15); similarly for the comprehensive set of Gencode
v19 transcripts (OR >72; P <10-15). However, only between
8,517 (UCSC) and 8,814 (Gencode) promoters are
expressed in MCF7 cells (FANTOM5 CAGE: >1 tags
per million mapped tags (TPM)). Still, even among
only the expressed promoters, E2F1 has a strong pref-
erence for CGI promoters (OR >9.4 (UCSC), >14.2
(Gencode); P <10-15).
Given the CGI preference of E2F1, we checked that
CGIs containing the CGCGC motif are indeed more
likely bound by E2F1 (OR >4.5; P <10-15). We then used
ENCODE RRBS-seq data for MCF7 cells to determine
the methylation state of CGIs: of the CGIs with suffi-
cient read coverage (see Methods for details), 12,358
were unmethylated (<20% median per-CpG methyla-
tion), 4,427 were methylated (>80%), and 1,468 were
hemimethylated. Relating the CGI methylation state to
E2F1 binding, we found E2F1 > 133x more likely to bind
to unmethylated versus methylated CGIs (P <10-15).
Using logistic regression, we then modelled the methyla-
tion state of a CGI in terms of its promoter activity and
E2F1 binding. Promoter activity and E2F1 binding were
both significantly negatively associated with CGI methy-
lation (P <10-15), the association being approximately
10x stronger for E2F1 binding (OR = 0.03 versus OR =
0.2 for promoter activity). Plotting of CGI promoter ac-
tivity versus the model prediction of CGI methylation
probability, stratified by E2F1 binding, revealed that
E2F1 binding in MCF7 cells is associated with a lack of
CGI methylation irrespective of the degree of CGI pro-
moter activity (Figure 8), consistent with our CGCGC
motif-based analysis for oocytes.
E2f1-3 are considered ‘activators’ since they induce H3
and H4 acetylation at target promoters [35]. DNA bind-
ing of E2f1 is required in particular for H4 acetylation,
and E2f1 directly interacts with the Kat5 (aka Tip60)
[35] histone acetyltransferase (HAT) complex whose
preferred targets include K5, K8, K12 and K16 of H4
[36]. This was observed in non-dividing cells, that is, the
results are relevant for oocytes where Kat5 also is highly
expressed [34].
The E2f family are also known to interact with the Swi/
Snf chromatin remodelling complex via Arid1a and Arid1b
[37]. Genes encoding Swi/Snf components (Smarca2,
Smarcb1, Smarcc2, Smarce1, Actl6a), and Arid1a as well as
Arid1b are highly expressed in mouse oocytes [33,34,38,39].
Like E2f1 and E2f2, Arid1b is highly expressed specifically
in oocytes [see Additional file 2: Figure S12] [33]. E2f1 and
Kat5 specifically interact with Arid1b, and in proliferating
cells, Arid1b is required for the binding of Swi/Snf to the
promoters of cell-cycle-specific genes [37]. The Swi/Snf
complex can move nucleosomes along DNA, and its
recruitment to nucleosomes is enhanced by histone acetyl-
ation [40].
Nucleosome-bound DNA is the preferred substrate of
the Dnmt3a/l complex, consistent with features of its
structure and the generation of strand-asymmetric pairs
of 5mC by its two active sites that are approximately
9 bp apart [18,23]. In addition, Dnmt3a has particularly
high affinity for H3K36me3-marked nucleosomes [41,42].
H3K36me3 follows transcriptional elongation [43], and
while overall being associated with deacetylation [44],
there is complex interplay with H4K16 acetylation [45]
along transcribed genes.
In this wider context, our findings support a model
(Figure 7.C) of E2f1 and/or E2f2 contributing to sequence-
specific protection of CGIs from de novo DNA methyla-
tion in the oocyte via the recruitment of Kat5 and Swi/Snf,
the latter removing nucleosomes from the CGI and thus
inhibiting Dnmt3a/l activity on the CGI sequence, even if
transcription proceeds through the CGI, which would nor-
mally lead to DNA methylation. Our analysis results for
human MCF7 cells indicate that E2f1 may play a role in
the regulation of DNA methylation at CGIs in somatic cell
types too.
Definitive proof of such a role for E2f1/2 will require
the genome-wide assessment of DNA methylation in
(oocyte-conditional) E2f1/2 knock-outs, direct observa-
tion of E2f1/2 binding in oocytes, and/or DNA methyla-
tion studies of specific loci with engineered deletions or
insertions of E2f1/2 recognition sites. Homozygous triple
knock-out mice for E2f1, E2f2 and a non-canonical
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isoform of E2f3 survive to adulthood, the only described
phenotype being a lower body weight [46]. While these
are unconditional knock-outs, they may provide an op-
portunity to study the effects of E2f1 and E2f2 deficiency
on DNA methylation in oocytes and during embryogen-
esis. Transcription factor ChIP-seq in oocytes remains a
technical challenge, but given the known E2f1 recogni-
tion motif, other, less demanding methods may prove
effective at identifying bona fide E2f1 binding sites in
oocytes [47].
Conclusions
Our results support a sequence-independent and tran-
scription elongation-driven model of de novo CGI methy-
lation during oogenesis. However, the vast majority of
CGIs resist de novo DNA methylation during oogenesis,
and we show that this resistance is associated with the
CGCGC DNA sequence motif. The motif is the recogni-
tion site consensus for two DNA-binding proteins, E2f1
and E2f2, involved in chromatin remodelling via Arid1b
and the Swi/Snf complex. E2f1, E2f2 and Arid1b are highly
expressed specifically in oocytes. On the basis of our re-
sults in this context, we propose that sequence-specific
E2f1 and/or E2f2 binding to CGIs in the oocyte confers
protection against de novo DNA methylation via nucleo-
some depletion by recruited Swi/Snf.
Methods
CpG island, gDMR and oocyte promoter coordinates
CGI coordinates, relative to mouse genome NCBI build
37, were taken from [13]. Permanent maternal gDMR
coordinates were taken from [14]. Promoter regions of
oocyte-expressed transcripts were defined as +/- 1 kbp
around the transcription start site (the start of the first
exon) of a Cufflinks-reconstructed transcript for which
Cufflinks was able to determine the strand of origin and
hence, the direction of transcription. Promoter regions
also had to overlap a CGI and a region of H3K4me3-
enrichment in growing oocyte [13].
Motif finding analyses
Motif analyses were conducted using modules of the
MEME suite [48] (version 4.9.0). DREME [17] was used
for ab initio motif search, FIMO [49] was used for search-
ing DNA sequences for motif occurrences, and TOMTOM
[50] was used for finding matches between motifs and
known recognition sites of DNA binding proteins.
High throughput sequencing analyses
Percent methylation values of CGIs were taken from
[12,13] for mouse GV and MII stage oocytes, and
MeDIP-seq-derived log-transformed methylation fold-
change values for mouse E8.5 embryos derived from
Figure 8 E2F1 binding of CpG islands (CGIs) in MCF7 cells is associated with lack of CGI methylation, independent of CGI promoter
activity. We fitted a logistic regression model to MCF7-specific data on the methylation state (M in {0, 1}; derived from ENCODE RRBS-seq;
see main text), promoter activity (P = log10 of maximum TPM observed by FANTOM5 CAGE) and E2F1 binding (E2F1 in {0, 1}; derived from [32];
see Methods) for 12,358 unmethylated (M = 0) and 4,427 methylated (M = 1) CGIs. All coefficients of the fitted model, M = logit(-1.31 -1.63*P
-3.49*E2F1 + 0.60*P*E2F1), were of significant magnitude (P <10-7), that is, promoter activity and E2F1 binding both were independently and
significantly negatively associated with CGI methylation, the degree of association being approximately 10x greater for E2F1. All terms of the
model, including the interaction term, significantly improved model fit (chi-squared P <10-6). The plot shows the relationship between the level
of CGI promoter activity (x-axis) and the probability of the CGI being methylated as predicted by the fitted model (y-axis), separately for CGIs
bound by E2F1 (E2F1+) versus for CGIs not bound by E2F1 (E2F1-). The probability is essentially zero for CGIs bound by E2F1, irrespective of the
level of their promoter activity, while in the absence of E2F1, the methylation state depends on the level of promoter activity, with only active
CGIs (x >0: TPM >1) dropping below the 20% methylation threshold (y <0.2) typically considered as unmethylated.
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Dnmt3L-deficient oocytes were taken from [14]. The
complete annotation of CGIs with methylation data is
part of the Additional file 4 and Additional file 5
(‘CGIs_methylation_Annotation’ spreadsheet).
The oocyte transcriptome was generated from analys-
ing mRNA-seq data for growing (d10, [13]) and fully
grown (d35, [13]; 7 to 8 week wild type and 7 to 15 week
Dnmt3L-deficient [12]) oocytes using the Tuxedo proto-
col [22], including alignment with Tophat [51] (Bowtie-1
[52]), per-sample transcript reconstruction with Cufflinks
[53] (v.2.0.1), and merging of per-sample reconstructed
transcripts with Cuffmerge [22] (v.2.0.1). The complete
annotation of CGIs with oocyte transcriptome data is
part of the Additional file 4 and Additional file 5 (‘CGIs_
transcripts_Annotation’ spreadsheet).
H3K4me3 ChIP-seq data for growing oocyte (d15,
[13]) were reanalysed. ChIP-seq reads over CGIs and
promoters of oocyte-expressed transcripts were counted
using HTSeq (http://www-huber.embl.de/users/anders/
HTSeq/). DESeq was used to normalise read counts for
differences in sequencing depth between samples, to ro-
bustly estimate the variance of read counts between
samples, and to variance-stabilise and log-transform the
read count data [54]. Subsequently, regions enriched for
H3K4me3 in the two IP samples compared to the inputs
were identified from a linear model fitted with limma [55].
Cfp1 ChIP-seq data [29] were reanalysed using USeq
[56] and MACS [57] with the default parameters. Since
input DNA data were not available, we used the input
samples for a CTCF ChIP-seq experiment in the same
tissue (whole mouse brain) instead [58]. The sequence
reads for the input samples were trimmed to be equal in
length to the immunoprecipitated (IP) samples.
CpG island classification
CGIs were classified into distinct classes related to their
location relative to oocyte expressed transcripts for
which the strand of origin could be determined by
Cufflinks. Promoter-associated CGIs (PA) overlap a 1
kbp region (enriched in H3K4me3) around the TSS by
at least 1 bp. Intragenic CGIs are located within a tran-
script, at least 1 kbp distant from the TSS. Distal intra-
genic CGIs overlap the 1 kbp region downstream from
the end of the transcript. End-associated CGIs overlap
the 1 kbp region around either the start or the end of a
transcript that lacks strand information.
CpG periodicity
The empirical distribution of the expected number of
CpG pairs at distances from 0 to 1,000 bp was generated
for each CGI from 1,000 independent permutations of
its nucleotides while maintaining the original frequencies
of all dinucleotides (dinucleotide frequency-invariant
DNA sequence shuffling [25]). The CpG positions in
each shuffled version of the sequence were recorded.
From these positions, a pair-wise distance matrix was
created. For each distance D from 0 to 1,000 or, if
smaller, the length of the island L less two (the max-
imum distance between two CpGs in a sequence of
length L is L-2), the number of CpG pairs was counted.
For each distance D, the 1,000 counts generated from
the 1,000 permutations of a sequence S form the empir-
ical, expected distribution of the number of CpG pairs at
distance D in S. Using this empirical distribution for S,
the rank and corresponding empirical P value of the ac-
tually observed number of CpG pairs at distance D in S
was determined. To test the significance of the number
of CpG pairs at distances between 8 and 10 bp, the
counts for these distances were added for each of the
1,000 permutations of S as well as for the original se-
quence S. The empirical p-value for this range of dis-
tances was then determined as above (the significance
threshold was 0.05).
From the permutation-generated expected distribu-
tions, for each S and D, the expected number of CpG
pairs in sequence S at distance D was derived by aver-
aging the counts obtained from the 1,000 permutations
of S. The expected number for S and D was used to
normalise the number of actually observed CpG pairs at
distance D in S, that is, observed over expected ratios
(obs/exp) were generated. Finally, the obs/exp ratios for
each distance D were averaged over all sequences in a
CGI category with L - 2 ≥D, where L is the length of the
sequence, that is, excluding sequences that are too short
to contain CpG pairs at distance D.
Re-analysis of E2F1 ChIP-seq in MCF7 cells
SRA files with the E2F1 ChIP-seq (SRR167632-3) and
input (SRR167638-40) reads were downloaded from the
NCBI Short Read Archive, converted to FASTQ with
fastq-dump from the SRA toolkit v2.3.5, and aligned to the
GRCh37 (hg19) human reference genome using Novoalign
v3.02.07. Calling of regions significantly enriched in the
E2F1 ChIP-seq samples over input and identification of
enriched DNA sequence motifs within those regions was
performed using GEM v2.4.1 [59].
Promoter regions were derived from the transcripts
annotated by UCSC Known Genes and, alternatively, by
Gencode (comprehensive transcript set v19) as the re-
gions from -1,500 bp to +500 bp of a TSS using Bash
and Perl scripts and Bedops v2.4.2 [60]. Overlapping and
abutting regions were merged. Each promoter region
was then annotated with the maximum number of FAN-
TOM5 CAGE tags per million mapped tags (TPM) that
was observed for a CAGE tag cluster in MCF7 cells
overlapping the promoter region [61].
Per CpG DNA methylation data for MCF7 cells gener-
ated by RRBS-seq were downloaded (GEO GSM683787
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and GSM683793). Correlation between the two replicate
samples was high (r2 = 97.97%) so that they were merged.
CpGs with <10x coverage were discarded. Bedops was
used to annotate each CGI from [10] with the number of
assayed CpGs and their median percent methylation
value.
The coordinates of occurrences of the CGCGC motif
in the GRCh37 (hg19) genome were determined using
dreg from the EMBOSS toolkit v6.6.0.
The above data set [see Additional file 7: BED format
files, some with extra columns containing annotation]
was the basis for overlap queries following filtering
performed with bedops, followed by Fisher’s exact tests
or logistic regression modelling in R. For example, TPM-
annotated promoters were filtered by TPM >1 to gener-
ate the subset of expressed promoters. Similarly, CGIs
were filtered by number of assayed CpGs >5, prior to de-
termining their methylation state and testing or linear
regression modelling.
Additional files
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Additional file 2: Supplementary Figures.
Additional file 3: Supplementary Results and Methods.
Additional file 4: Description of supplementary spreadsheets.
Additional file 5: Supplementary spreadsheets.
Additional file 6: Mini-website with GEM peak calling and motif
analysis results for E2F1 ChIP-seq in MCF7 cells.
Additional file 7: BED files with data underlying the statistical
analyses of the E2F1 ChIP-seq peaks in MCF7 cells; coordinates are
for the hg19 human reference genome build.
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